CASTLEARK MANAGEMENT LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
CASTLEARK MANAGEMENT LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,259,943
+235.8%
90,980
+350.2%
0.10%
+292.3%
Q3 2021$673,000
-91.6%
20,211
-90.2%
0.03%
-90.3%
Q2 2021$8,020,000
-23.5%
206,761
-5.0%
0.27%
-28.8%
Q1 2021$10,490,000
+32.7%
217,631
+43.3%
0.38%
+27.7%
Q4 2020$7,903,000
+135.8%
151,916
+21.3%
0.30%
+126.0%
Q3 2020$3,351,000125,2100.13%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,647,000$6,423,0000.45%
DAFNA Capital Management LLC 75,000$293,0000.30%
Baker Brothers Advisors 2,199,656$8,579,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 71,105$277,0000.05%
SMITH ASSET MANAGEMENT GROUP LP 196,684$767,0000.03%
SABBY MANAGEMENT, LLC 66,000$257,0000.02%
THOMPSON DAVIS & CO., INC. 1,000$4,0000.01%
COLUMBUS CIRCLE INVESTORS 161,919$631,0000.00%
JENNISON ASSOCIATES LLC 455,271$1,776,0000.00%
BlackRock Fund Advisors 448,445$1,749,0000.00%
View complete list of TG THERAPEUTICS INC shareholders